Franklin FTSE Europe ETF (FLEE)
Live price chart, market sentiment, and community perspectives for Franklin FTSE Europe ETF (AMEX: FLEE).
Live price chart, market sentiment, and community perspectives for Franklin FTSE Europe ETF (AMEX: FLEE).
As a hedge fund portfolio manager evaluating FLEE, I am noting the attractive valuation cushion provided by the 14.74 P/E multiple compared to the SandP 500. However, the macroeconomic backdrop in the eurozone remains sluggish. While the ECB's ongoing rate-cutting cycle offers a structural tailwind for our financial sector allocations—which sit at roughly 25.5% of the fund—we need a stronger growth catalyst before committing aggressively to a long-term overweight stance.
From a quantitative perspective, our predictive AI models indicate that FLEE is currently caught in a mid-channel oscillation pattern. We are observing divergent sentiment readings across horizons that point to choppy trading conditions. Specifically, our quantitative setups are flagging attractive short-term risk-reward parameters targeting minor percentage pullbacks from recent price levels around $40.05, should current resistance levels hold firm.
On our risk management desk, we see FLEE carrying a 3-year risk score of 77, designating it as aggressive on the Morningstar scale. Its 5-year maximum drawdown of -29.3% aligns closely with the category median of -30.9%, and its 3-year beta of 0.94 confirms tight index tracking to the FTSE Developed Europe RIC Capped Index. We are monitoring these metrics closely alongside its low expense ratio of 9 basis points.
Looking at the fundamental income attributes of FLEE, the trailing twelve-month dividend yield of 3.10% provides a steady baseline return for long-term allocators. Combined with an expense ratio of just 0.09% and total net assets hovering around $118.33 million as of mid-2026, the fund offers a highly cost-effective vehicle for passive market-cap-weighted exposure to developed European equities.
Reviewing short interest data for FLEE as of late July 2026, short interest sits at 1,586 shares, representing just 0.05% of the public float. Although this marks a 301.52% increase from the prior month's low baseline of 395 shares, the days-to-cover ratio remains exceptionally low at 0.3 days based on average trading volumes. This tells me that short selling pressure is practically negligible and not driving the recent price pullback.
Explore plasma cleansing, somatic organ swaps, and BCI.